Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05849064 · ClinicalTrials.gov registry record · NA
Concussion Treatment in Older Adults
A NA study of Concussion, Mild, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05849064: Recruiting NA study of Concussion, Mild, sponsored by University of Pittsburgh.
NCT05849064 is a NA study of Concussion, Mild that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05849064, a NA study of Concussion, Mild, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.
Primary Outcome
The CP Screen is a 29 item self-report, clinical profiles based symptom inventory that measures five concussion clinical profiles: 1) anxiety/mood, 2)cognitive/fatigue, 3) migraine, 4) ocular, 5) vestibular; and two modifying factors sleep and cervical. Participants indicate on a scale of 0 (none) to 3 (severe) the level of symptom severity for each item. The CP screen yields an average factor and modifier scores, with higher scores indicative of worse symptom severity, score range is 0-87.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Control
- BEHAVIORAL Targeted Intervention
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05849064 shows while recruiting
NCT05849064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Concussion, Mild appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Control is the first listed.
NCT05849064 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05849064 about?
NCT05849064 is a clinical study titled "Concussion Treatment in Older Adults". The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with...
What is the current status of trial NCT05849064?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-07. Estimated completion is 2026-07.
What conditions does trial NCT05849064 study?
This clinical trial studies the following conditions: Concussion, Mild.
What interventions are being tested in trial NCT05849064?
The interventions under investigation include: Behavioral Control (BEHAVIORAL), Targeted Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05849064?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05849064 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussion, Mild
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05849064's enrollment target sits among peer trials
50 14th of 18 higher than 5 of 18 other Concussion, Mild trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Concussion, Mild trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT
RECRUITING · NA
-
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
RECRUITING · NA
-
Facilitating Access to Specialty Treatment
RECRUITING · NA
-
Mobile Subthreshold Exercise Program for Concussion--R01
ACTIVE NOT RECRUITING · NA
-
Concussion Prevention in Female Soccer Athletes
COMPLETED · NA
-
The Combined Effect of Chronic Cannabis Use and Subconcussive Head Impacts on Brain Health
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI